SEARCH RESULTS for NOVARTIS AG

Recent Patent Assignments Patent Assignments - (Total found: 366)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
21-Feb-2018

(X0) 15517872: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

(A1) 20170306038: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC.

NOVARTIS AG

44962/574

21-Feb-2018

(X0) 15517872: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

(A1) 20170306038: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44962/552

19-Feb-2018

(X0) 14714914: SYNTHETIC APELIN MIMETICS FOR THE TREATMENT OF HEART FAILURE

(A1) 20150252076: SYNTHETIC APELIN MIMETICS FOR THE TREATMENT OF HEART FAILURE

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

44953/149

16-Feb-2018

(X0) 15661132: Organic Compositions to Treat Beta-ENaC-Related Diseases

(A1) 20170327829: Organic Compositions to Treat Beta-ENaC-Related Diseases

ALNYLAM PHARMACEUTICALS, INC.

NOVARTIS AG

44945/925

16-Feb-2018

(X0) 15661132: Organic Compositions to Treat Beta-ENaC-Related Diseases

(A1) 20170327829: Organic Compositions to Treat Beta-ENaC-Related Diseases

DIENER, JOHN L.

PULICHINO, ANNE-MARIE

HICKMAN, EMMA

NOVARTIS AG

44945/414

15-Feb-2018

(X0) 15791857: SURGICAL MICROSCOPE WITH INTEGRATED OPTICAL COHERENCE TOMOGRAPHY AND DISPLAY SYSTEMS

(A1) 20180045927: SURGICAL MICROSCOPE WITH INTEGRATED OPTICAL COHERENCE TOMOGRAPHY AND DISPLAY SYSTEMS

ALCON RESEARCH, LTD.

NOVARTIS AG

44249/174

15-Feb-2018

(X0) 15233711: SUBRETINAL FLUID DRAINAGE INSTRUMENTS, SYSTEMS, AND METHODS

(A1) 20180042768: SUBRETINAL FLUID DRAINAGE INSTRUMENTS, SYSTEMS, AND METHODS

ALCON RESEARCH, LTD.

NOVARTIS AG

40532/807

15-Feb-2018

(X0) 15686454: ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE

(A1) 20180044410: ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

43601/491

15-Feb-2018

(X0) 15730773: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES

(A1) 20180044549: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES

QIU, YONGXING

PRUITT, JOHN DALLAS

THEKVELI, SIBICHEN J.

TUCKER, ROBERT CAREY

NELSON, JARED

NOVARTIS AG

44005/73

13-Feb-2018

(X0) 14100298: Method and Packaging Plant for Placing Product Packages into Shipment Containers

(A1) 20140157732: Method and Packaging Plant for Placing Product Packages into Shipment Containers

(B2) 9889954: Method and Packaging Plant for Placing Product Packages into Shipment Containers

GASBER, DIRK

N/A

NOVARTIS AG

32672/90

13-Feb-2018

(X0) 14892616: IMIDAZOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

(A1) 20160108047: IMIDAZOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

(B2) 9890166: IMIDAZOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

37218/764

08-Feb-2018

(X0) 15532634: METHODS AND COMPOSITIONS USING KLOTHO VARIANT POLYPEPTIDES

(A1) 20180037623: METHODS AND COMPOSITIONS USING KLOTHO VARIANT POLYPEPTIDES

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

42573/280

08-Feb-2018

(X0) 15643170: EXTRACTION OF MICROSCOPE ZOOM LEVEL USING OBJECT TRACKING

(A1) 20180039060: EXTRACTION OF MICROSCOPE ZOOM LEVEL USING OBJECT TRACKING

ALCON RESEARCH, LTD.

NOVARTIS AG

43426/773

08-Feb-2018

(X0) 15643170: EXTRACTION OF MICROSCOPE ZOOM LEVEL USING OBJECT TRACKING

(A1) 20180039060: EXTRACTION OF MICROSCOPE ZOOM LEVEL USING OBJECT TRACKING

ALCON RESEARCH, LTD.

NOVARTIS AG

43816/861

08-Feb-2018

(X0) 15651845: Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk Patients

(A1) 20180036315: Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk Patients

NOVARTIS PHARMA AG

NOVARTIS AG

43798/813

08-Feb-2018

(X0) 15517867: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

(A1) 20170306037: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC.

NOVARTIS AG

44860/736

08-Feb-2018

(X0) 15651845: Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk Patients

(A1) 20180036315: Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk Patients

NOVARTIS PHARMA AG

NOVARTIS AG

43799/99

08-Feb-2018

(X0) 15517867: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

(A1) 20170306037: COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44860/674

06-Feb-2018

(X0) 14234648: MUTANT PARVOVIRUS VP1 UNIQUE REGION POLYPEPTIDES AND COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

(A1) 20140170187: MUTANT PARVOVIRUS VP1 UNIQUE REGION POLYPEPTIDES AND COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

(B2) 9884892: MUTANT PARVOVIRUS VP1 UNIQUE REGION POLYPEPTIDES AND COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

NOVARTIS AG

39082/301

06-Feb-2018

(X0) 15317532: AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

(A1) 20170121282: AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

(B2) 9884817: AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION

N/A

NOVARTIS AG

41532/626

06-Feb-2018

9884913: ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

44467/256

06-Feb-2018

9884913: ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

COSTIM PHARMACEUTICALS INC.

N/A

NOVARTIS AG

44467/230

06-Feb-2018

(X0) 14888995: INTERACTIONS OF BETANODAVIRUSES IN INFECTION

(A1) 20160095915: INTERACTIONS OF BETANODAVIRUSES IN INFECTION

(B2) 9884103: INTERACTIONS OF BETANODAVIRUSES IN INFECTION

NOVARTIS ANIMAL HEALTH CANADA INC.

N/A

NOVARTIS AG

36957/269

06-Feb-2018

9884913: ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

N/A

NOVARTIS AG

44467/265

05-Feb-2018

(X0) 15304010: Administration of Bimagrumab for Improving Muscle Mass and Function After Hip Fracture Surgery

(A1) 20170029513: Administration of Bimagrumab for Improving Muscle Mass and Function After Hip Fracture Surgery

NOVARTIS PHARMA AG

NOVARTIS AG

44810/858

05-Feb-2018

(X0) 15304010: Administration of Bimagrumab for Improving Muscle Mass and Function After Hip Fracture Surgery

(A1) 20170029513: Administration of Bimagrumab for Improving Muscle Mass and Function After Hip Fracture Surgery

NOVARTIS PHARMACEUTICALS CORPORATION

NOVARTIS AG

44810/926

05-Feb-2018

(X0) 14816975: VIBRATION SYSTEMS AND METHODS

(A1) 20150340590: VIBRATION SYSTEMS AND METHODS

NOVARTIS PHARMA AG

NOVARTIS AG

44814/223

01-Feb-2018

(X0) 15551768: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

(A1) 20180028497: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

NOVARTIS PHARMA AG

NOVARTIS AG

43382/209

01-Feb-2018

(X0) 15551768: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

(A1) 20180028497: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

NOVARTIS PHARMACEUTICALS CORPORATION

NOVARTIS AG

43382/220

01-Feb-2018

(X0) 15664680: INTEGRATED OPHTHALMIC SURGICAL SYSTEM

(A1) 20180028355: INTEGRATED OPHTHALMIC SURGICAL SYSTEM

ALCON RESEARCH, LTD.

NOVARTIS AG

43432/452

01-Feb-2018

(X0) 15659130: Toric Contact Lens Having A Ballast Mark Representing A Lens Identification Code

(A1) 20180031863: Toric Contact Lens Having A Ballast Mark Representing A Lens Identification Code

CIBA VISION GMBH

NOVARTIS AG

43543/968

01-Feb-2018

(X0) 15641955: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

(A1) 20180028641: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

NOVARTIS VACCINES & DIAGNOSTICS SRL

NOVARTIS AG

43682/505

01-Feb-2018

(X0) 15524197: AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE

(A1) 20170355731: AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE

NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION

NOVARTIS AG

44785/269

01-Feb-2018

(X0) 15222059: PRESSURE CONTROL IN PHACOEMULSIFICATION SYSTEM

(A1) 20180028359: PRESSURE CONTROL IN PHACOEMULSIFICATION SYSTEM

ALCON RESEARCH, LTD.

NOVARTIS AG

39284/321

01-Feb-2018

(X0) 15225146: METHOD AND APPARATUS FOR PERFORMING OPHTHALMIC PROCEDURES REMOVING UNDESIRABLE FEATURES USING LASER ENERGY

(A1) 20180028354: METHOD AND APPARATUS FOR PERFORMING OPHTHALMIC PROCEDURES REMOVING UNDESIRABLE FEATURES USING LASER ENERGY

ALCON RESEARCH, LTD.

NOVARTIS AG

39305/406

01-Feb-2018

(X0) 15551768: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

(A1) 20180028497: PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

NOVARTIS PHARMA S.A.S.

NOVARTIS AG

43382/191

31-Jan-2018

(X0) 15167867: PHARMACEUTICAL COMPOSITIONS COMPRISING AN AROMATSE INHIBITORS

(A1) 20160346257: PHARMACEUTICAL COMPOSITIONS COMPRISING AN AROMATSE INHIBITORS

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44772/464

30-Jan-2018

(X0) 14858878: CONTACT LENS MOUNTING SPECULUM FOR VITREORETINAL SURGERY

(A1) 20170079528: CONTACT LENS MOUNTING SPECULUM FOR VITREORETINAL SURGERY

(B2) 9877648: CONTACT LENS MOUNTING SPECULUM FOR VITREORETINAL SURGERY

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

36604/272

30-Jan-2018

9877868: APPARATUS FOR DISSECTING AN EYE FOR THE INTRODUCTION OF A PHOTOSENSITIZER

9877868: APPARATUS FOR DISSECTING AN EYE FOR THE INTRODUCTION OF A PHOTOSENSITIZER

WAVELIGHT GMBH

N/A

N/A

NOVARTIS AG

35403/683

30-Jan-2018

(X0) 14547572: COLORED INK FOR PAD TRANSFER PRINTING OF SILICONE HYDROGEL LENSES

(A1) 20150076721: COLORED INK FOR PAD TRANSFER PRINTING OF SILICONE HYDROGEL LENSES

(B2) 9880324: COLORED INK FOR PAD TRANSFER PRINTING OF SILICONE HYDROGEL LENSES

QUINN, MICHAEL HUGH

CARLSON, GREGORY

ATKINS, BARRY L.

N/A

NOVARTIS AG

34289/721

29-Jan-2018

(X0) 15408485: MODIFIED VP1-CAPSID PROTEIN OF PARVOVIRUS B19

(A1) 20170260239: MODIFIED VP1-CAPSID PROTEIN OF PARVOVIRUS B19

NOVARTIS PHARMA AG

NOVARTIS AG

44742/725

26-Jan-2018

(X0) 14770765: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

(A1) 20160010089: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

(B2) 9868949: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

N/A

NOVARTIS AG

44722/964

25-Jan-2018

(X0) 15604556: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

(A1) 20180022825: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

NOVARTIS PHARMA AG

NOVARTIS AG

44074/144

25-Jan-2018

(X0) 14881888: ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

(A1) 20160108123: ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

COSTIM PHARMACEUTICALS INC.

NOVARTIS AG

44712/252

25-Jan-2018

(X0) 14770765: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

(A1) 20160010089: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

(B2) 9868949: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES

ALNYLAM PHARMACEUTICALS, INC.

N/A

NOVARTIS AG

44711/579

25-Jan-2018

(X0) 15604556: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

(A1) 20180022825: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

NOVARTIS PHARMA AG

NOVARTIS AG

44025/602

25-Jan-2018

(X0) 15550224: PROCESS AND INTERMEDIATES FOR THE PREPARATION OF NEP INHIBITORS

(A1) 20180022690: PROCESS AND INTERMEDIATES FOR THE PREPARATION OF NEP INHIBITORS

NOVARTIS PHARMA AG

NOVARTIS AG

43541/229

25-Jan-2018

(X0) 15604556: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

(A1) 20180022825: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44025/529

25-Jan-2018

(X0) 15709504: METHODS AND SYSTEMS FOR PULSED ILLUMINATION

(A1) 20180021101: METHODS AND SYSTEMS FOR PULSED ILLUMINATION

ALCON GRIESHABER AG

NOVARTIS AG

43636/12

25-Jan-2018

(X0) 15653070: METHOD FOR INSPECTING AN OPHTHALMIC LENS USING OPTICAL COHERENCE TOMOGRAPHY

(A1) 20180024077: METHOD FOR INSPECTING AN OPHTHALMIC LENS USING OPTICAL COHERENCE TOMOGRAPHY

CIBA VISION GMBH

NOVARTIS AG

43331/244